glp-1 moa and Anesthesia: Considerations and Cautions for CRNAs GLP-1 Agonists For Obesity In
Description
doi: 10.1016/j.medcli.2023.05.021
Arillotta D, Floresta G, Papanti Pelletier GD, Guirguis A, Corkery JM, Martinotti G, Schifano F
Cell Tissue Res
Implications for Healthspan and Mortality Reduction Overall, individuals with SMIs account for a disproportionate share of years of life lost and disability-adjusted life years
These mediators are called pro-inflammatory cytokines and are the main culprits for launching and sustaining inflammation
